Navigation Links
Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
Date:4/3/2008

willingness to use 'methods to put them into a creative state and keep them in this state, for as long as they wished,' gave higher grades in most of the survey's parameters: (i.e., they are more independent in their work, more idealistic, and they attach more importance to creativity and spiritually than others)," noted Devor. Worthy of note is that economic and other incentives were not considered sufficiently significant to make scientists accept these risks. Methods to reduce psychological and/or physiological risks, as opposed to economic incentives, were more effective in promoting the willingness to experiment with methods of entering a creative state (42% gave a grade of 7- 10, indicating willingness to accept these risks). "Quite simply," Devor concluded, "it seems that they believe that increased creativity can improve their work."

A statistical regression was made in order to determine the parameters that most influence the intention of using methods to induce a state of creativity. Three parameters were found to be significantly influential. The most influential parameter was:

To what extent did you feel that there was more to 'perceive'

had you only had the opportunity to remain longer in the creative state?"

Those who responded positively were those who expressed a greater willingness to try methods to put them in a creative state.
The other two parameters were:

"If it were in my power, I would want to increase this ratio"

(inspiration/perspiration ratio)

and

"I have a special method or technique (internal or external)

for inducing creativity in myself."

"Thanks to this survey," states Project Mind director David Devor, "it could be said that a small step has been made towards dramatically improving the standard of creativity in scientific research worldwide."

For further information: Please contact David S. Devor: devor@usa.net'/>"/>

SOURCE Project Mind
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bioscience Career Fair in San Francisco Projected to Break Job Seeker Attendance Records
2. Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project
3. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
4. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
5. Credit-card-sized platform for volatile compound analysis CAREER project goal
6. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
7. ADM, MGSC and ISGS Announce Carbon Sequestration Project
8. Nano-Science Center to coordinate EU-project
9. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
10. Elbit Medical Imaging Ltd. Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore, India
11. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...and, November 24 deCODE,... approval of all of its,"first day" motions by the...e,(the "Bankruptcy Court"). deCODE last week filed...of the United States Bankruptcy Code with the,Bank...Bankruptcy Court allow the company to continue,to ...
(Date:11/24/2009)... Blue Marble Energy Corp. announced today that the...ty (OPDA) were recently awarded $2 million by Wash...oard (CERB) in a private/public partnership to con...refinery in Lincoln County, WA. ,, "This inve... our biorefinery and bring over 70 green jobs to L...
(Date:11/24/2009)...wire-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: S...pany, today,announced that it has submitted a MAA ... alfa, the company,s enzyme replacement therapy in...isease. This is the third marketing,application fo... previous,submissions in the United States and Can...
(Date:11/24/2009)...ustomers with Partners Validated to Process and An... , Ottawa, ON (PRWEB) Nove... of products for biological sample collection, sta...w global partner program. The program offers signi...unity and is designed to help partners scale and d...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... Corporation,today announced its V-Link Luer-activ...ing, the first needleless intravenous (IV) connect...ilable for hospitals in the,United States and Cana... on,average 99.9 percent or more of specific commo...use catheter-related bloodstream,infections. Patho...
...scussed during Omnicell,educational, programs Apr...nd April,22 at, The Mid-America Club in Chicago, ..., Omnicell, Inc. (Nasdaq: OMCL ), a leading provi...nd operational efficiency in,healthcare facilities...uccessful implementation of SinglePointe(TM), a to...
...., Ph.D. a,physician-geneticist and leader of the ...the inaugural Inamori Ethics Prize from the Inamor...t Case Western Reserve,University., (Photo: http..., The Inamori Ethics Prize honors outstanding int...ly to an individual who has demonstrated,exemplary...
Other Biology Technology:Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 4Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 2Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 3Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 2Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 3Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 4
(Date:11/24/2009)...Scientists have crystallised a protein that may he.... The protein could be used by probiotic producers... benefit to people. , "Probiotics need to interac...ffect, and if they attach to surfaces in the gut t... exert their activity," says Dr Nathalie Juge from...
(Date:11/24/2009)... BATON ROUGE Antarctica has long held secrets of... until recently, there has been very little inform...neath miles of ice for millions of years. Now, a t...ng LSU have been funded to the tune of $10 millio...SF, to get to the bottom of things literally. The...
(Date:11/23/2009)...Washington, D.C. The community-associated strain ...cteria resistant to most common antibioticsposes a...nd is making its way into hospitals, according to ...ous Diseases . , The new threat is easily picke... places and has increased the overall burden of MR...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation 52200 1The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation 52200 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 1JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 2JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 3JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 4
...by Stephen Dalton, professor and Georgia Research ...he University of Georgia, has been awarded $9.2 mi... National Institute of General Medical Sciences, p...n,s group, headquartered in the department of bioc...olecular underpinnings of the early steps that ste...
...has waged a successful guerrilla war against the h...eek,s Journal of Biological Chemistry has expose...immune proteins, which may aid in future drug deve...mitted to people via infected mosquitoes. Once ins...hop in liver cells, then move into red blood cells...
...cting vast amounts of diverse genomic data with ev...ze these data in an integrated manner have lagged ...is growing need, researchers at the Broad Institut...IGV), a novel and freely available visualization t...analyze different types of genomic data, and gives...
Other Biology News:UGA researchers win $9.2 million stem cell grant from NIH 2Research exposes new target for malaria drugs 2Broad Institute researchers introduce next generation tool for visualizing genomic data 2
Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Anti-Tropomyosin 4 Antibody, Unconjugated from CHEMICON
Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Biology Products: